查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715541

全球血管支架市場按產品類型、材料、輸送系統、應用和最終用戶分類——預測至 2025 年至 2030 年

Vascular Stent Market by Product Type, Material, Delivery System, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血管支架市場價值將達到100.9億美元，2024年將成長至106.5億美元，複合年成長率為5.88%，到2030年將達到150.6億美元。

主要市場統計數據
基準年2023年 100.9億美元
預計2024年 106.5億美元
預測年份 2030 150.6億美元
複合年成長率（%） 5.88%

隨著世界各地的醫療保健系統持續應對心血管和周邊血管疾病的沉重負擔，血管支架市場正呈現出新的重要角色。在技​​術創新和臨床需求的交匯下，這個市場正在發展成為支持先進治療性介入的關鍵支柱。

支架留置技術的不斷發展不僅僅是提高手術的安全性和有效性；它反映了個人化醫療、微創技術和快速技術採用等更廣泛的趨勢。隨著人口老化以及冠狀動脈疾病、胃腸道併發症和周邊動脈疾病盛行率的顯著增加，對可靠和創新的血管支架的需求顯然日益增加。

該分析對這個充滿活力的市場提供了全面的概況。我們首先澄清近年來所見的演變的背景和理由。我們既關注宏觀經濟趨勢，也關注引領這股轉型浪潮的微觀轉變，為深入研究細分、區域動態和競爭格局奠定基礎。

血管支架市場的變革浪潮

血管支架市場的轉型正以不容忽視的能量展開。設備輸送系統的持續技術創新、材料科學的進步以及監管改革都在重新定義這些設備的構思、製造和臨床應用方式。近年來，支架逐漸向新一代功能轉變，為不僅更加耐用、生物相容性更強，而且能夠更好地根據患者需求提供治療益處的產品鋪平了道路。

藥物釋放型和生物可吸收材料等技術突破在性能和安全性方面樹立了新的標準。聚合物科學的快速發展促進了先進聚合物支架的興起，尤其是生物分解性的設計，有望降低與永久性植入相關的長期風險。同時，數位和遠端健康監測技術的進步使醫生能夠對術後護理做出更明智的決定，從而顯著改善患者的治療效果。

全球監管和政策改革也在這一演變中發揮關鍵作用。這些監管改革正在促進產品核可並簡化創新設備推向市場的途徑，直接影響突破性技術進入臨床的速度。此外，不斷增加的研發投入和產業參與者之間的策略聯盟正在加速創新和商業化的循環。

這些變革性變化象徵著醫療保健領域正朝著更全面化、技術支援和以患者為中心的方向發展。隨著這些趨勢繼續滲透到市場，人們仍然專注於改善臨床結果、簡化程序干預以及為整個行業帶來永續的進步。

血管支架生態系關鍵環節分析

對血管支架市場的詳細研究可以透過細分視角揭示關鍵見解。根據產品類型，市場大致分為球囊擴張型支架和自動擴張型支架，這兩類支架均可滿足特定的臨床需求和程序偏好。這種分類非常重要，因為它概述了與每種支架類型相關的最佳應用設定和特定效能特徵。

進一步觀察材料成分，細分反映了一種雙重方法，將支架分為金屬支架和聚合物支架。區分生物分解性和非生物分解的聚合物增強了聚合物技術的潛力。生物分解性聚合物因其能夠降低永久植入的長期風險和併發症越來越受歡迎。

輸送系統也透過詳細描述裸金屬支架、覆膜支架和藥物洗脫支架的頻譜，呈現出引人注目的細分敘述。每種輸送機制在操作簡便性和治療效果方面都有各自的優勢，其中藥物釋放型支架透過將機械支撐與局部藥物治療相結合以防止血管再阻塞，具有巨大的潛力。

此外，在分析基於應用的細分時，重點關注冠狀動脈疾病、胃腸道疾病和周邊動脈疾病等主要疾病。最後一點透過區分下肢和上肢進一步細化，說明在複雜的解剖和生理情況下需要客製化解決方案。最後，基於最終用戶的細分顯示了各種設置，例如門診手術中心、心臟中心、醫院等。此最終用戶分析揭示了最有可能採用和實施先進置入術解決方案的分銷管道和醫療保健基礎設施，為市場滲透和成長提供了清晰的藍圖。

每個細分都有助於多層次地了解市場動態，促進產品開發、分銷管道最佳化和加強臨床參與的有針對性的策略。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 心血管疾病的全球流行
      • 微創手術的採用率不斷提高
    • 限制因素
      • 醫療保健專業人員對血管支架的長期有效性和安全性越來越關注。
    • 機會
      • 加大對支架設計創新研發活動的投入
      • 將智慧技術融入血管支架，提高安全性和有效性
    • 任務
      • 嚴格的監管標準和核准程序帶來的複雜性
  • 市場區隔分析
    • 產品類型：球囊擴張型支架因其在複雜動脈通路導航中的精確性和有效性而越來越受到青睞。
    • 材質：金屬支架因其耐用性和維持血管通暢性的有效性而得到越來越廣泛的應用。
    • 輸送系統：藥物釋放型支架因其在治療慢性疾病和複雜病變方面的有效性而越來越受到青睞
    • 應用：微創手術的需求正在推動冠狀動脈疾病（CAD）中血管支架的擴展
    • 最終用戶：為了獲得更優質的護理和更快的康復，門診手術中心對血管支架的採用有所增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 血管支架市場（依產品類型）

  • 球囊擴張型支架
  • 自動擴張型支架

第7章血管支架市場（依材料）

  • 金屬支架
  • 聚合物支架
    • 生物分解性聚合物
    • 非生物分解的聚合物

8. 血管支架市場（依輸送系統）

  • 裸金屬支架
  • 覆膜支架
  • 藥物釋放型支架

9. 血管支架市場（依應用）

  • 冠狀動脈疾病
  • 胃腸道疾病
  • 周邊動脈疾病
    • 下肢
    • 上肢

第 10 章血管支架市場（依最終用戶）

  • 門診手術中心
  • 心臟中心
  • 醫院

11.美洲血管支架市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太血管支架市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲血管支架市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Artivion Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Blue Sail Medical Co., Ltd
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Elixir Medical Corporation
  • Endologix LLC
  • iVascular, SLU
  • Kaneka Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Lombard Medical Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Microport Scientific Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Purple MicroPort Cardiovascular Pvt. Ltd
  • Sahajanand Medical Technologies Limited
  • Stryker Corporation
  • Terumo Corporation
  • Translumina GmbH
  • WL Gore & Associates, Inc.
Product Code: MRR-034B5003037F

The Vascular Stent Market was valued at USD 10.09 billion in 2023 and is projected to grow to USD 10.65 billion in 2024, with a CAGR of 5.88%, reaching USD 15.06 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 10.09 billion
Estimated Year [2024] USD 10.65 billion
Forecast Year [2030] USD 15.06 billion
CAGR (%) 5.88%

The vascular stent market has taken on new importance as healthcare systems around the globe continue to address the significant burden of cardiovascular and peripheral vascular diseases. In an environment where innovation intersects with clinical need, this market has evolved into a critical pillar that supports advanced therapeutic interventions.

The ongoing development of stenting technologies is not merely confined to improvements in procedural safety and efficacy, but it also mirrors the broader trends of personalized medicine, minimally invasive techniques, and rapid technological adoption. With an aging population and a marked increase in the prevalence of conditions such as coronary artery disease, gastrointestinal complications, and peripheral arterial disease, the increased demand for reliable and innovative vascular stents is palpable.

This analysis offers a comprehensive overview of the dynamic market. It begins by establishing a clear context and rationale for the evolution witnessed over recent years. It draws attention to both macroeconomic trends and micro-level shifts that have spearheaded a wave of transformative changes, setting the stage for an in-depth exploration of segmentation, regional dynamics, and competitive landscapes.

Transformative Shifts in the Vascular Stent Market

The transformation of the vascular stent market unfolds with an energy that is unmissable. Ongoing innovations in device delivery systems, material science advancements, and regulatory reforms have all redefined the way these devices are conceived, manufactured, and clinically applied. In recent years, there has been a marked shift towards integrating next-generation features into stents, making way for products that not only enhance durability and biocompatibility but also offer tailored therapeutic benefits according to patient needs.

Technological breakthroughs, such as drug-eluting capabilities and bioresorbable materials, have set new benchmarks in performance and safety. Fast-tracked developments in polymer science have contributed to the rise of advanced polymeric stents, particularly those designed to be biodegradable, which promise to mitigate long-term risks associated with permanent implants. Simultaneously, the evolution of digital and remote health monitoring technologies has fostered an environment where physicians can make more informed decisions about post-procedural care, significantly improving patient outcomes.

Global regulations and policy reforms have also played a crucial role in this evolution. These regulatory changes have spurred product approvals and streamlined pathways for introducing innovative devices to the market, directly impacting how quickly groundbreaking technologies can reach clinical settings. In addition, increased investments in research and development along with strategic collaborations among industry players have accelerated the cycle of innovation and commercialization.

The transformative shifts are emblematic of a broader move towards a more integrated, technology-enabled, and patient-centric approach to healthcare. As these trends continue to permeate the market, the focus remains on delivering enhanced clinical outcomes, efficiency in procedural interventions, and a sustainable path forward for the industry at large.

Key Segmentation Insights in the Vascular Stent Ecosystem

An in-depth examination of the vascular stent market reveals significant insights through the lens of segmentation. An analysis based on product type indicates that the market is largely partitioned into balloon-expandable stents and self-expanding stents, with both categories catering to specific clinical needs and procedural preferences. This classification is crucial as it outlines the optimal application settings and the inherent performance characteristics associated with each stent type.

Looking further into the material composition, the segmentation reflects a dual approach that is categorized into metallic stents and polymeric stents. The opportunity within polymeric technology is enhanced by distinguishing between biodegradable and non-biodegradable polymers. This aspect of segmentation not only highlights the clinical versatility and performance but also underpins the strategic research focus, as biodegradable polymers are gaining traction for their capability to reduce the long-term risks and complications of permanent implants.

The delivery system also presents a compelling segmentation narrative by detailing the spectrum of bare metal stents, covered stents, and drug-eluting stents. Each delivery mechanism embodies unique advantages in terms of procedural ease and therapeutic effectiveness, with drug-eluting variants offering significant promise by combining mechanical support with localized drug therapy to thwart restenosis.

Furthermore, when analyzing application-based segmentation, the focus rests on key conditions including coronary artery disease, gastrointestinal disease, and peripheral artery disease. The last of these is further nuanced by distinguishing between lower extremities and upper extremities, which exemplifies the need for tailored solutions in complex anatomical and physiological contexts. Finally, segmentation based on the end-user presents an array of settings such as ambulatory surgical centers, cardiac centers, and hospitals. This end-user analysis underscores the distribution channels and the healthcare infrastructure that is most likely to adopt and implement advanced stenting solutions, thereby providing a clear roadmap for market penetration and growth.

Each of these segmentation facets contributes to a layered understanding of the market dynamics, facilitating targeted strategies for product development, distribution channel optimization, and enhanced clinical engagement.

Based on Product Type, market is studied across Balloon-Expandable Stents and Self-Expanding Stents.

Based on Material, market is studied across Metallic Stents and Polymeric Stents. The Polymeric Stents is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.

Based on Delivery System, market is studied across Bare Metal Stents, Covered Stents, and Drug Eluting Stents.

Based on Application, market is studied across Coronary Artery Disease, Gastrointestinal Disease, and Peripheral Artery Disease. The Peripheral Artery Disease is further studied across Lower Extremities and Upper Extremities.

Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.

Regional Dynamics Steering Market Growth

The geographical landscape in which the vascular stent market operates is as diverse as the clinical applications it serves. Across the Americas, there is a strong prevalence of cardiovascular and peripheral vascular diseases, which drives significant demand for advanced stent technologies. In addition, investments in state-of-the-art healthcare facilities and an increasing focus on minimally invasive procedures solidify the region's role as a key market for innovative stenting solutions.

In the Europe, Middle East & Africa region, the emphasis on quality healthcare combined with supportive regulatory frameworks has led to steady market expansion. The regulatory environment in these areas is characterized by clear guidelines and robust approval processes, which in turn fosters a competitive market landscape for both established and emerging companies. Public and private healthcare collaborations along with consistent R&D investments further underpin the region's growth.

Meanwhile, the Asia-Pacific region is notable for its rapid urbanization and rising standards of healthcare. The segment is witnessing accelerated adoption of innovative medical devices spurred by governmental support and evolving clinical infrastructures. As emerging economies continue to invest in advanced healthcare technologies, both the demand and supply of vascular stents are expected to continue trending upward. This region has shown an appetite for breakthrough technologies that promise both efficacy and cost-efficiency, which in turn drives significant market opportunities.

Altogether, these regional insights highlight the importance of localized market strategies that account for diverse healthcare infrastructures, economic conditions, and regulatory environments. The interplay of these factors determines how each region adapts and leverages new technologies in the fight against vascular diseases.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Leading Company Insights

A detailed competitive analysis reveals an intricate tapestry of industry leaders who have progressively shaped the market. Renowned players such as Abbott Laboratories, Amaranth Medical, Inc., and Artivion Inc. have established strongholds in product innovation and market penetration. Their relentless focus on research, development, and clinical validation has set the stage for significant advancements in stenting technologies.

Other companies such as B. Braun SE, Becton, Dickinson and Company, and Biotronik SE & Co. KG have also contributed actively to expanding the product portfolio. These organizations not only leverage deep clinical insights but also capitalize on strategic alliances that dovetail with the evolving needs of healthcare providers. Firms like Blue Sail Medical Co., Ltd, in conjunction with Boston Scientific Corporation and Cardinal Health, Inc., have placed a significant emphasis on integrating advanced delivery systems and specialized stent materials that cater to diverse clinical requirements.

The competitive momentum is further buoyed by contributors such as Cook Group Incorporated, Elixir Medical Corporation, and Endologix LLC. These companies focus on refining the mechanics of stent deployment and optimizing patient outcomes by addressing multifactorial clinical challenges. Innovators like iVascular, S.L.U and Kaneka Corporation have brought to the market novel biocompatibility solutions that emphasize both functionality and safety.

Not to be overlooked are the visionary roles played by Kyoto Medical Planning Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., and Lombard Medical Ltd. Their strategic investments in research and geographic expansions have enabled these players to secure vital market positions. Medtronic PLC and Meril Life Sciences Pvt. Ltd, along with other key players such as Microport Scientific Corporation, Otsuka Medical Devices Co., Ltd., and Purple MicroPort Cardiovascular Pvt. Ltd, continue to push the envelope with ground-breaking clinical trials and product innovations.

Additional notable insights are driven by companies including Sahajanand Medical Technologies Limited, Stryker Corporation, Terumo Corporation, Translumina GmbH, and W. L. Gore & Associates, Inc. Together, these industry leaders create a competitive ecosystem where rigorous performance benchmarks, innovative delivery systems, and diversified product offerings drive market growth and continuous improvements in patient care.

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amaranth Medical, Inc., Artivion Inc., B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Blue Sail Medical Co., Ltd, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Elixir Medical Corporation, Endologix LLC, iVascular, S.L.U, Kaneka Corporation, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology(Beijing)Co.,Ltd., Lombard Medical Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Otsuka Medical Devices Co., Ltd., Purple MicroPort Cardiovascular Pvt. Ltd, Sahajanand Medical Technologies Limited, Stryker Corporation, Terumo Corporation, Translumina GmbH, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Industry Leaders

Leaders in the vascular stent market should adopt a multi-dimensional strategy to remain at the forefront of this evolving landscape. First, investing in advanced research and development is crucial for staying ahead of market trends and meeting the nuanced needs of patients. It is essential to focus on refining both material composition and device design to further improve safety profiles and clinical outcomes. Recognizing the shift towards biodegradable polymers and drug-eluting technologies can incentivize future innovations that cater to personalized treatment strategies.

Next, forging robust partnerships with key clinical institutions and pivotal thought leaders can enhance the depth of clinical insights while also expanding product reach. Collaborations with regulatory experts will likely streamline market entry and accelerate approval processes in various regions. In doing so, companies can not only reduce time-to-market but also broaden their portfolio through well-integrated product lines.

Investing in digitization and data analytics is another key recommendation. By leveraging big data, real-time monitoring, and predictive analytics, industry leaders can better understand customer needs, track post-market performance, and preemptively address potential product issues. This strategic integration of digital solutions can empower decision-makers with actionable insights and foster more informed clinical decisions.

Finally, there is high strategic value in adopting a region-specific market approach. Tailoring products and marketing strategies to align with localized clinical practices and regulatory norms serves as a robust pathway to tapping into the unique opportunities within the Americas, Europe, Middle East & Africa, and Asia-Pacific. Embracing such a multi-pronged strategy can position industry leaders to capture emerging market segments and to anticipate shifts in global demand effectively.

Conclusion: Navigating a Dynamic Future in Vascular Stents

In summary, the vascular stent market continues to undergo profound transformations driven by technological advancements, regulatory changes, and evolving clinical demands. The intricate segmentation based on product type, material, delivery systems, and application categories provides a comprehensive view of the competitive nuances influencing the industry. Further, the regional analyses across the Americas, Europe, Middle East & Africa, and Asia-Pacific highlight both opportunities and challenges that are unique to each area.

The convergence of innovation, regulatory evolution, and strategic commercial initiatives promises a dynamic future for the market. Companies that remain agile, invest in robust research, and emphasize digital integrations will likely set the benchmark for future advancements. Ultimately, the trajectory of the market reaffirms the substantial role that vascular stents continue to play in modern medical interventions.

As research deepens and the market matures, stakeholders are encouraged to align their strategic priorities with emerging trends, sustainable innovations, and targeted market-driven approaches. This comprehensive perspective not only underscores the importance of advanced stent technologies but also lays the groundwork for a more resilient and patient-centric healthcare ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding global prevalence of cardiovascular diseases
      • 5.1.1.2. Increasing adoption of minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to the long-term efficacy and safety of vascular stents among healthcare providers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments in research and development activities for innovation in stent designs
      • 5.1.3.2. Integration of smart technology in vascular stents offering enhanced safety and efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with the stringent regulatory standards and approval procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing preference for balloon-expandable stents for precision and effectiveness in navigating complex arterial paths
    • 5.2.2. Material: Increasing utilization of metallic stents owing to their durability and efficacy in maintaining vascular patency
    • 5.2.3. Delivery System: Increasing preference for drug-eluting stents owing to their effectiveness in managing chronic conditions and complex lesions
    • 5.2.4. Application: Expanding applications of vascular stents in coronary artery disease (CAD) owing to the need for minimally invasive procedures
    • 5.2.5. End-Users: Growing adoption of vascular stent in ambulatory surgical centers for high-quality care and rapid recovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Stent Market, by Product Type

  • 6.1. Introduction
  • 6.2. Balloon-Expandable Stents
  • 6.3. Self-Expanding Stents

7. Vascular Stent Market, by Material

  • 7.1. Introduction
  • 7.2. Metallic Stents
  • 7.3. Polymeric Stents
    • 7.3.1. Biodegradable Polymers
    • 7.3.2. Non-Biodegradable Polymers

8. Vascular Stent Market, by Delivery System

  • 8.1. Introduction
  • 8.2. Bare Metal Stents
  • 8.3. Covered Stents
  • 8.4. Drug Eluting Stents

9. Vascular Stent Market, by Application

  • 9.1. Introduction
  • 9.2. Coronary Artery Disease
  • 9.3. Gastrointestinal Disease
  • 9.4. Peripheral Artery Disease
    • 9.4.1. Lower Extremities
    • 9.4.2. Upper Extremities

10. Vascular Stent Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Cardiac Centers
  • 10.4. Hospitals

11. Americas Vascular Stent Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vascular Stent Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Stent Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Translumina expands global footprint with UAE operations, leveraging Indian innovation in vascular stents
    • 14.3.2. R3 Vascular Inc. secures USD 87 million funding, and targets breakthrough in PAD treatment with next-gen bioresorbable scaffold
    • 14.3.3. GE HealthCare's 3DStent tackles expansion challenges in complex cases by revolutionizing stent visualization
    • 14.3.4. Artivion amends agreements with Endospan to provide additional funding for FDA approval
    • 14.3.5. Boston Scientific acquires Silk Road Medical to enhance vascular intervention capabilities
    • 14.3.6. Philips launched Duo Venous Stent system to advance innovative solutions in venous outflow obstruction treatment
    • 14.3.7. Kaneka's strategic partnership with Rapid Medical set to revolutionize Japan's stent retriever market with TIGERTRIEVER launch
    • 14.3.8. Strategic partnership between SMT and HeartX to revolutionize congenital heart defect treatment worldwide
    • 14.3.9. Abbott introduces Xience Sierra coronary stent system for enhanced heart patient care
    • 14.3.10. Cook Medical secures DOD Contract, strengthening market position and fostering growth in vascular stent sector
    • 14.3.11. Terumo India advances cardiovascular care with Ultimaster Nagomi Stent launch
    • 14.3.12. Kaneka Corporation acquires Japan Medical Device Technology to revolutionize coronary stent innovation
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Stryker Corporation
    • 14.4.2. Medtronic PLC
    • 14.4.3. Boston Scientific Corporation
    • 14.4.4. Abbott Laboratories

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amaranth Medical, Inc.
  • 3. Artivion Inc.
  • 4. B. Braun SE
  • 5. Becton, Dickinson and Company
  • 6. Biotronik SE & Co. KG
  • 7. Blue Sail Medical Co., Ltd
  • 8. Boston Scientific Corporation
  • 9. Cardinal Health, Inc.
  • 10. Cook Group Incorporated
  • 11. Elixir Medical Corporation
  • 12. Endologix LLC
  • 13. iVascular, S.L.U
  • 14. Kaneka Corporation
  • 15. Kyoto Medical Planning Co., Ltd.
  • 16. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 17. Lombard Medical Ltd.
  • 18. Medtronic PLC
  • 19. Meril Life Sciences Pvt. Ltd
  • 20. Microport Scientific Corporation
  • 21. Otsuka Medical Devices Co., Ltd.
  • 22. Purple MicroPort Cardiovascular Pvt. Ltd
  • 23. Sahajanand Medical Technologies Limited
  • 24. Stryker Corporation
  • 25. Terumo Corporation
  • 26. Translumina GmbH
  • 27. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. VASCULAR STENT MARKET MULTI-CURRENCY
  • FIGURE 2. VASCULAR STENT MARKET MULTI-LANGUAGE
  • FIGURE 3. VASCULAR STENT MARKET RESEARCH PROCESS
  • FIGURE 4. VASCULAR STENT MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR STENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR STENT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR STENT MARKET SIZE, BY COVERED STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY GASTROINTESTINAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR STENT MARKET SIZE, BY LOWER EXTREMITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR STENT MARKET SIZE, BY UPPER EXTREMITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR STENT MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 323. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023